Stay updated on Bepirovirsen in Chronic Hepatitis B Clinical Trial
Sign up to get notified when there's something new on the Bepirovirsen in Chronic Hepatitis B Clinical Trial page.

Latest updates to the Bepirovirsen in Chronic Hepatitis B Clinical Trial page
- ChecktodayChange DetectedThe page's revision stamp was updated from v3.5.4 to v3.5.5, indicating a small template/update to the page rendering. This change does not alter study data or published results.SummaryDifference0.0%

- Check7 days agoChange DetectedA Publications subsection has been added featuring a PubMed citation for Phase 3 results of Bepirovirsen and a note that publications are auto-filled from PubMed.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedRecruitment status updated from Active, not recruiting to Completed. New Chinese sites were added with updated postal codes Hangzhou 310022, Liuzhou 545006, and Shenzhen 518112, while outdated site entries were removed.SummaryDifference0.3%

- Check29 days agoChange DetectedA new trial site has been added in Liuzhou, China, and Liuchow, China has been removed from the Locations list.SummaryDifference0.0%

- Check43 days agoChange DetectedThe page revision/version is updated from **v3.5.2** to **v3.5.3**, indicating a system or site software update rather than any change to the study information.SummaryDifference0.0%

- Check50 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2 on the page.SummaryDifference0.0%

Stay in the know with updates to Bepirovirsen in Chronic Hepatitis B Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Bepirovirsen in Chronic Hepatitis B Clinical Trial page.